Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial - Jackson, D J; Bacharier, L B; Gergen, P J (Lancet, 2022)
et al.